You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML evolving from myeloproliferative disorders (MPD)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Secondary Leukemia
  • Multiomic characterization
  • In vitro drug screening
  • (no location specified)
Aug 28, 2023

Blasts More Than 20 Percent of Bone Marrow Nucleated Cells, Blasts More Than 20 Percent of Peripheral Blood White Cells,

Completed
Has Results
  • Blasts More Than 20 Percent of Bone Marrow Nucleated Cells
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

Recruiting
  • AML
  • +8 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 13, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Tumor (MDS/MPN) Trial in Durham (ADCT-301)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Durham, North Carolina
    Duke University Health System
Jan 10, 2022

AML, Advanced MDS, ALL Trial in Chicago, New York (OTS167IV)

Terminated
  • AML
  • +4 more
  • Chicago, Illinois
  • +1 more
Nov 15, 2021

Acute Myeloid Leukemia, Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor Trial in Canada, United States

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
  • +9 more
Aug 30, 2021

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States

Recruiting
  • Acute Myelogenous Leukemia (AML)
  • +5 more
  • Conditioning Chemotherapy
  • Cord blood graft
  • Basking Ridge, New Jersey
  • +6 more
May 22, 2023

Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

Dysregulated Signaling in MPD Via Multiparameter

Terminated
  • Myeloproliferative Disorders
  • Myeloproliferative Disorders (MPD)
    • Stanford, California
      Stanford University School of Medicine
    Apr 7, 2020

    Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder Trial in Seongnam, Seoul (Ruxolitinib)

    Recruiting
    • Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder
    • Seongnam, Korea, Republic of
    • +1 more
    Mar 18, 2020

    MDS, Myeloproliferative Tumor, Acute Myeloid Leukemia Trial in Cleveland (Azacitidine, Ascorbic acid)

    Completed
    • Myelodysplastic Syndromes
    • +2 more
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    Aug 4, 2021

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • (no location specified)
    Nov 8, 2022

    Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Cytokine Induced Memory-like Natural Killer Cells
    • Interleukin-2
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2023

    Acute Myeloid Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumor Trial in Worldwide (BGB-11417, Azacitidine, Posaconazole)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Houston, Texas
    • +23 more
    Aug 18, 2022

    Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Minimal Residual Disease Trial in Seattle (procedure,

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia in Remission
    • +5 more
    • Allogeneic Bone Marrow Transplantation
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    May 13, 2021

    Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

    Withdrawn
    • Leukemia
    • Donor Enriched Activated Natural Killer Cell Infusion
    • (no location specified)
    Dec 20, 2022

    Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

    Recruiting
    • Myeloproliferative Neoplasm
    • +7 more
      • Hong Kong, Hong Kong
        Department of Medicine, Queen Mary Hospital
      May 21, 2023

      Myeloproliferative Disorders, Lymphoproliferative Disorders Trial in Pierre-Bénite (Blood collection for the evaluation of the

      Not yet recruiting
      • Myeloproliferative Disorders
      • Lymphoproliferative Disorders
      • Blood collection for the evaluation of the anti-drugs sensitivity
      • Pierre-Bénite, France
      • +1 more
      Mar 2, 2022

      Epigenetic Age on Clinic-biological Presentation and Prognosis

      Not yet recruiting
      • Myeloproliferative Neoplasm
      • Assessment of the epigenetic age
      • Bordeaux, France
        CHU de Bordeaux, service Hématologie Biologique
      Aug 28, 2023

      Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Hackensack (Fludarabine and Busulfan

      Active, not recruiting
      • Myeloid Malignancies
      • +4 more
      • Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
      • Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
      • Hackensack, New Jersey
        John Theurer Cancer Center at Hackensack University Medical Cent
      Feb 25, 2022

      Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

      Recruiting
      • Acute Myeloid Leukemia
      • +6 more
      • Hyperbaric oxygen
      • Rochester, New York
        Wilmot Cancer Institute, University of Rochester
      May 16, 2022

      Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

      Recruiting
      • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
      • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 6, 2023